| Factor Information | |
|---|---|
| Data ID | 3695 |
| Factor | Magnesium values at 18 hours after bypass |
| Description | Magnesium values remained at this elevated level in the magnesium therapy group, and decreased to normal pre-operative values within 24 h in controls (P<0.001). |
| Biomarker | NA |
| Classification | E2 (physiological factor - biochemical index) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | To check the hypothesis that continuous magnesium infusion protects the heart from arrhythmias following cardiopulmonary bypass surgery for congenital heart disease. |
| p Value | <0.001 |
| Conclusion | There were significant differences between ionised magnesium values at 6 and 18 h (0.82±0.26 mmol l-1 and 0.86±0.26 mmol l-1 versus 0.64±0.11 mmol l-1 and 0.58±0.11 mmol l-1 Mg++ at 6 and 18 h in the study and control groups, respectively, P<0.001 |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 690 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | ASD/VSD/AVSD/LVOTO/AAO/SVES/EAT/AF/atrioventricular re-entry tachycardia/JET/VES/AV block |
| Reference | |
|---|---|
| PMID | 12774159 |
| Year | 2003 |
| Title | Randomised trial on the influence of continuous magnesium infusion on arrhythmias following cardiopulmonary bypass surgery for congenital heart disease. |
| Sample | ||
|---|---|---|
| Population | children | |
| Source | serum | |
| Region | Berlin, Germany | |
| Method | Mann–Whitney U test for unpaired samples and the two-sided Pearson’s chi-squared test | |
| Race | European | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | the magnesium therapy group(Treatment) | the control group received placebo(Control) |
| Number | 65 | 66 |
| Age | 15±2 years | 14±2 years |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | 0.82±0.26 mmol/L | 0.58±0.11 mmol/L |
